NCT00036361View on ClinicalTrials.gov

Broad Effectiveness: Study With Aripiprazole

PHASE3CompletedINTERVENTIONAL
Enrollment

444

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Aripiprazole

Trial Locations (1)

Unknown

Local Institution, Wallingford

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY